Monopar Therapeutics Inc Strategic Asset Allocation Index
Monopar Therapeutics Inc strategic asset allocation index. Monopar Therapeutics Inc (MNPR) has a Strategic Asset Allocation Index of 0.5% as of June 2023. Strategic assets (PP&E of $37.33K plus long-term investments of $-) total $37.33K, measured against net assets of $7.84 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check MNPR intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Monopar Therapeutics Inc Strategic Asset Allocation Index by Year (None–None)
Monopar Therapeutics Inc strategic asset allocation index by year from None to None. The table below presents the year-by-year Strategic Asset Allocation Index for Monopar Therapeutics Inc from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see MNPR market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|